TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9424897

Group type: EXPERIMENTAL
Intervention: Immediate repair of biliary tract injuries
Number of subjects: 112

Group type: COMPARATOR
Intervention: Secondary repair of biliary tract injuries
Number of subjects: 112

Group type: COMPARATOR
Intervention: Overall surgical treatment
Number of subjects: 112
Study: 8176086

Group type: EXPERIMENTAL
Intervention: Palmaz-Schatz stenting
Number of subjects: 200
Study: 2589377

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin combined with benzylpenicillin (CB)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Netilmicin combined with piperacillin (NP)
Number of subjects: 96
Study: 1145958

Group type: EXPERIMENTAL
Intervention: Scheie procedure
Number of subjects: 71

Group type: COMPARATOR
Intervention: Trabeculectomy with a sutured scleral flap
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 71
Study: 31911179

Group type: EXPERIMENTAL
Intervention: Moringa oleifera (MO) 400 mg/kg body weight
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Moringa oleifera hard gelatin capsules
Number of subjects: 15
Study: 31456039

Group type: EXPERIMENTAL
Intervention: Anxious depression group
Number of subjects: 126

Group type: COMPARATOR
Intervention: MDD-only group
Number of subjects: 126

Group type: COMPARATOR
Intervention: Comparison of depressed patients with and without comorbid anxiety disorders
Number of subjects: 126
Study: 28805348

Group type: EXPERIMENTAL
Intervention: Levocarnitine administered 0 and 30 min before each hemodialysis session
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo administered 0 and 30 min before each hemodialysis session
Number of subjects: 33
Study: 26537991

Group type: EXPERIMENTAL
Intervention: Capsulorhexis diameter of 3.0-3.9 mm (Group A)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Capsulorhexis diameter of 4.0-5.0 mm (Group B)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Capsulorhexis diameter of 5.1-6.0 mm (Group C)
Number of subjects: 38
Study: 23601628

Group type: EXPERIMENTAL
Intervention: Exercise prescription based on physical fitness test results and personal choice
Number of subjects: 72

Group type: COMPARATOR
Intervention: Nutrition intervention
Number of subjects: 72
Study: 21480939

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) combined with oral hygiene instructions (OHI)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Oral hygiene instructions (OHI) alone
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Responders (both groups)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: MMP‐8
Number of subjects: 68
Study: 19797730

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (DXM) 40 mg/day for four consecutive days
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: In vitro effects of DXM on peripheral blood mononuclear cells (PBMCs)
Number of subjects: 17
Study: 17113554

Group type: COMPARATOR
Intervention: CQ+SP (Homapak)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: AQ+SP
Number of subjects: 183
Study: 14760910

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chloroform
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (Dentin chips obtained before treatment)
Number of subjects: 20
Study: 10793106

Group type: EXPERIMENTAL
Intervention: Paclitaxel-cisplatin regimen
Number of subjects: 680

Group type: COMPARATOR
Intervention: Cyclophosphamide-cisplatin regimen
Number of subjects: 680
Study: 8803392

Group type: EXPERIMENTAL
Intervention: CEREC (Siemens AG) CAD‐CAM inlay restorations
Number of subjects: 28
Study: 1732569

Group type: COMPARATOR
Intervention: Standard regimen of 11 mg/kg of amikacin every 12 hours
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Individualized pharmacokinetic analysis adjusted amikacin regimens
Number of subjects: 28
Study: 6517973

Group type: EXPERIMENTAL
Intervention: Cessation of cigarette smoking
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 107
Study: 31425751

Group type: EXPERIMENTAL
Intervention: 1-step: 2-h, 75 g, oral glucose tolerance test (OGTT)
Number of subjects: 23792

Group type: COMPARATOR
Intervention: 2-step: 1-h, 50 g glucose challenge test (GCT) followed by 3-h, 100 g OGTT if GCT-positive
Number of subjects: 23792
Study: 28737128

Group type: EXPERIMENTAL
Intervention: Test formulation of oseltamivir 75-mg capsule
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference formulation Tamiflu®
Number of subjects: 20
Study: 27566367

Group type: EXPERIMENTAL
Intervention: Adalimumab monotherapy
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Adalimumab with azathioprine (25-100mg daily)
Number of subjects: 176
Study: 25332331

Group type: EXPERIMENTAL
Intervention: Hypocaloric nutritional support (50% of calculated daily caloric requirement of 25-30 kcal · kg(‐1) · d(‐1))
Number of subjects: 83

Group type: COMPARATOR
Intervention: Eucaloric nutritional support (standard calculated daily caloric requirement of 25-30 kcal · kg(‐1) · d(‐1))
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Hypocaloric nutritional support
Number of subjects: 83

Group type: COMPARATOR
Intervention: Eucaloric nutritional support
Number of subjects: 83
Study: 21895712

Group type: EXPERIMENTAL
Intervention: Sertraline treatment
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 19930005

Group type: EXPERIMENTAL
Intervention: Exenatide 5-10 microg b.i.d.
Number of subjects: 235

Group type: COMPARATOR
Intervention: Insulin glargine o.d.
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 235

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 235
Study: 17966778

Group type: EXPERIMENTAL
Intervention: New graduated dilator with a standard treatment schedule (20 patients)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Multiple anal dilators (20, 23, 27 mm) with a standard treatment schedule (20 patients)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: New graduated dilator according to a free treatment schedule (20 patients)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Graduated anal dilator according to a free treatment schedule
Number of subjects: 60
Study: 15371831

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg daily
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8000
Study: 11248773

Group type: COMPARATOR
Intervention: DDDR pacing
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: DDDR+CAP pacing
Number of subjects: 61

Group type: COMPARATOR
Intervention: DDDR pacing (less than 50% atrial pacing)
Number of subjects: 61

Group type: COMPARATOR
Intervention: DDDR pacing (less than 90% atrial pacing)
Number of subjects: 61
Study: 10350928

Group type: EXPERIMENTAL
Intervention: Virtual reality environment viewed through a head-mounted display
Number of subjects: 0

Group type: COMPARATOR
Intervention: Virtual reality environment viewed on a two-dimensional computer screen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phobic virtual environment exposure
Number of subjects: 0
Study: 7989211

Group type: EXPERIMENTAL
Intervention: Usual care plus exercise (group B1)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Usual care plus exercise plus teaching‐counseling sessions (group B2)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Usual medical and nursing care (control group A)
Number of subjects: 258
Study: 2486557

Group type: EXPERIMENTAL
Intervention: Coronary angioplasty
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Coronary artery bypass surgery
Number of subjects: 1000
Study: 30734085

Group type: EXPERIMENTAL
Intervention: 500 mg calcium supplement
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study: 28109321

Group type: EXPERIMENTAL
Intervention: SW-CRCTs
Number of subjects: 123
Study: 25943912

Group type: EXPERIMENTAL
Intervention: Fast-Track Surgery (FTS-1)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Fast-Track Surgery (FTS-2)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Conventional Care (CC-1)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Conventional Care (CC-2)
Number of subjects: 256
Study: 22580904

Group type: EXPERIMENTAL
Intervention: Constraint‐induced movement therapy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Intensive bimanual training
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 105
Study: 22221683

Group type: EXPERIMENTAL
Intervention: Lidocaine group (n = 40): 1 mL (10 mg) nalbuphine diluted with 1 mL lidocaine (20 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline group (control) (n = 40): 1 mL (10 mg) nalbuphine diluted with 9 mL normal saline
Number of subjects: 80
Study: 19401804

Group type: EXPERIMENTAL
Intervention: 4000U Botulinum toxin type B (BTX-B)
Number of subjects: 36
Study: 16557440

Group type: EXPERIMENTAL
Intervention: OTCI
Number of subjects: 50

Group type: COMPARATOR
Intervention: MCI
Number of subjects: 50
Study: 12752837

Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention program (staff education, environmental adjustment, exercise, drug review, aids, hip protectors, postfall problem-solving conferences)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 378
Study: 11103860

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 84

Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 84
Study: 9193126

Group type: EXPERIMENTAL
Intervention: Self-directed treatment with minimal therapist contact (five meetings, readings, self-directed exposure with response prevention)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Waiting period (6-week delay before treatment)
Number of subjects: 9
Study: 1735279

Group type: EXPERIMENTAL
Intervention: bid dosing (4 inhalations bid)
Number of subjects: 16

Group type: COMPARATOR
Intervention: qid dosing (2 inhalations qid)
Number of subjects: 16
Study: 3992162

Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-restricted diet (Control)
Number of subjects: 55
Study: 30519577

Group type: EXPERIMENTAL
Intervention: Low-Temperature Plasma Radiofrequency Ablation (LTP-RFA)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Carbon Dioxide Laser Microsurgery (CO2-LS)
Number of subjects: 131
Study: 26381054

Group type: EXPERIMENTAL
Intervention: Macitentan 10 mg at steady state
Number of subjects: 26

Group type: COMPARATOR
Intervention: Combined Oral Contraceptive (OC) alone (reference)
Number of subjects: 26
Study: 25200821

Group type: EXPERIMENTAL
Intervention: Transcervical falloposcopy tubal dilatation (TFTD) after laparoscopic salpingolysis, salpingostomy
Number of subjects: 468

Group type: COMPARATOR
Intervention: Laparoscopic salpingolysis, salpingostomy
Number of subjects: 468
Study: 23354115

Group type: EXPERIMENTAL
Intervention: Teriparatide (daily subcutaneous injection of 20 μg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Bisphosphonate (daily oral administration of 2.5 mg of risedronate)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (without medication for osteoporosis)
Number of subjects: 62
Study: 21206545

Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17940144

Group type: EXPERIMENTAL
Intervention: Repair of both the rotator cuff and type II SLAP lesion (group 1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Repair of the rotator cuff and tenotomy of the long head of the biceps (group 2)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Comparison of group 1 and group 2
Number of subjects: 63
Study: 16798472

Group type: EXPERIMENTAL
Intervention: Exercise group (EXE) - prescribed and supervised 4 h/week brisk walking on a treadmill at 50% to 85% of heart rate reserve
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Exercise group (EXE)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Change on Hallux VPT from baseline to the end of the study
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Change on Malleolus VPT between the two groups
Number of subjects: 78
Study: 14713374

Group type: EXPERIMENTAL
Intervention: Multimedia condition (narrated animation)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Unimodal condition (visually presented worked examples)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional condition (solving conventional problems)
Number of subjects: 120
Study: 10096378

Group type: EXPERIMENTAL
Intervention: 6 months of neoadjuvant combined androgen blockade (CAB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3 months of neoadjuvant combined androgen blockade (CAB)
Number of subjects: 40
Study: 7674681

Group type: EXPERIMENTAL
Intervention: High dose of alcohol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Active-placebo
Number of subjects: 40
Study: 2297598

Group type: EXPERIMENTAL
Intervention: Memory notebook logging
Number of subjects: 6

Group type: COMPARATOR
Intervention: Written rehearsal
Number of subjects: 6

Group type: COMPARATOR
Intervention: Verbal rehearsal
Number of subjects: 6

Group type: COMPARATOR
Intervention: Acronym formation
Number of subjects: 6
Study: 7042888

Group type: EXPERIMENTAL
Intervention: Fresh concentrated Egyptian liquid BCG vaccine (2 mg/ml) given in gradually increasing doses.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (11 patients) did not receive any further treatment after chemotherapy.
Number of subjects: 21
Study: 30446398

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 5449

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DES) with longer DAPT (>6 months)
Number of subjects: 5449

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DES) with shorter DAPT
Number of subjects: 5449

Group type: COMPARATOR
Intervention: Bare-Metal Stents (BMS)
Number of subjects: 5449
Study: 28771493

Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (LNS) 20g daily
Number of subjects: 3436

Group type: COMPARATOR
Intervention: Zinc supplementation (Z-Suppl)
Number of subjects: 3436
Study: 25767103

Group type: EXPERIMENTAL
Intervention: 2-yearly endoscopic surveillance
Number of subjects: 3400

Group type: COMPARATOR
Intervention: 'At need' endoscopy
Number of subjects: 3400
Study: 23829890

Group type: EXPERIMENTAL
Intervention: nab-P 260 mg/m(2) q3w with bevacizumab 15 mg/kg q3w
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: nab-P 260 mg/m(2) q2w with filgrastim and bevacizumab 10 mg/kg q2w
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: nab-P 130 mg/m(2) weekly with bevacizumab 10 mg/kg q2w
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but includes all arms)
Number of subjects: 208
Study: 20890204

Group type: EXPERIMENTAL
Intervention: Tinnitus retraining therapy (TRT) with acoustic stimulation devices and 3 months of individual counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: General counseling without additional sound therapy
Number of subjects: 0
Study: 18792423

Group type: EXPERIMENTAL
Intervention: Group counselling
Number of subjects: 62

Group type: COMPARATOR
Intervention: Individual counselling
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 16548952

Group type: EXPERIMENTAL
Intervention: Computer integrated patient controlled epidural analgesia (CI‐PCEA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Demand only patient controlled epidural analgesia (PCEA)
Number of subjects: 40
Study: 12732396

Group type: EXPERIMENTAL
Intervention: Carriers of the 53A allele
Number of subjects: 0

Group type: COMPARATOR
Intervention: 53G homozygotes
Number of subjects: 0

Group type: COMPARATOR
Intervention: L125V polymorphism
Number of subjects: 0
Study: 11269551

Group type: EXPERIMENTAL
Intervention: EndoGIA laparoscopic appendectomy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Endoloop laparoscopic appendectomy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Extracorporeal laparoscopically assisted appendectomy
Number of subjects: 150
Study: 9699090

Group type: EXPERIMENTAL
Intervention: Increased urinary albumin excretion (UAE)
Number of subjects: 320
Study: 8120515

Group type: EXPERIMENTAL
Intervention: Selenium and vitamin E treatment (1.6 mg selenium and 800 mg vitamin E daily for 4 months)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo treatment (corresponding number of placebo tablets)
Number of subjects: 27
Study: 2680285

Group type: EXPERIMENTAL
Intervention: Fenticonazole ovule (600 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Clotrimazole vaginal tablet (500 mg)
Number of subjects: 50
Study: 1106277

Group type: EXPERIMENTAL
Intervention: Azathioprine (3 to 4 mg/kg of body weight) plus prednisone (60 mg per day initially)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prednisone (60 mg per day initially)
Number of subjects: 24
Study: 7217546

Group type: EXPERIMENTAL
Intervention: Parent training plus methylphenidate
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Methylphenidate only
Number of subjects: 43

Group type: COMPARATOR
Intervention: Parent training in behavior modification with placebo
Number of subjects: 43
Study: 31933482

Group type: EXPERIMENTAL
Intervention: DRV+COBI
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ATV+COBI
Number of subjects: 36

Group type: COMPARATOR
Intervention: drospirenone/EE
Number of subjects: 36
Study: 30100300

Group type: EXPERIMENTAL
Intervention: Active joint motion foam rolling
Number of subjects: 30

Group type: COMPARATOR
Intervention: No joint motion foam rolling
Number of subjects: 30
Study: 28479909

Group type: EXPERIMENTAL
Intervention: Individualized education (one-on-one counseling and individualized management plan)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Group education (control group)
Number of subjects: 280
Study: 24445089

Group type: EXPERIMENTAL
Intervention: Combination therapy of backward walking exercise and alpha-lipoic acid (ALA) treatment (ALA for 2 weeks, backward walking exercise for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Alpha-lipoic acid (ALA) treatment (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination therapy of backward walking exercise and alpha-lipoic acid (ALA) treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Backward walking exercise
Number of subjects: 60
Study: 23098173

Group type: EXPERIMENTAL
Intervention: Dispositional catastrophizing ratings (pre-to-post changes)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Situational catastrophizing ratings (pre-to-post changes)
Number of subjects: 57
Study: 20335368

Group type: EXPERIMENTAL
Intervention: Platinum-fluorouracil plus cetuximab
Number of subjects: 442

Group type: COMPARATOR
Intervention: Platinum-fluorouracil
Number of subjects: 442
Study: 17701403

Group type: EXPERIMENTAL
Intervention: Stimulant
Number of subjects: 76
Study: 16304254

Group type: EXPERIMENTAL
Intervention: Nasal or inhaled beclomethasone dipropionate (BDP) administered separately or in combination for 16 weeks after a 2-week placebo run-in period
Number of subjects: 74
Study: 12153963

Group type: EXPERIMENTAL
Intervention: Pulmonary hemodynamics assessment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cardiac index assessment
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Correlation analysis of mean pulmonary artery pressure
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Multiple stepwise regression analysis
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Assessment of diastolic ventricular pressures
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Conclusions drawn from the study
Number of subjects: 120
Study: 10981083

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment to a diastolic blood pressure of less than or equal to 80 mm Hg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment to a blood pressure goal of less than 150/85 mm Hg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment to the lowest diastolic blood pressure goal of less than or equal to 80 mm Hg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attainment of lower blood pressure goal
Number of subjects: 0
Study: 8551116

Group type: EXPERIMENTAL
Intervention: Hydrocolloidal dressing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rice paper patch
Number of subjects: 30
Study: 1983509

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) - Embolex‐LM, n = 464
Number of subjects: 1510

Group type: COMPARATOR
Intervention: Standard heparin (Liquemin), n = 452
Number of subjects: 1510

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) - Sandoparin, n = 298
Number of subjects: 1510

Group type: COMPARATOR
Intervention: Standard heparin, n = 296
Number of subjects: 1510

Group type: EXPERIMENTAL
Intervention: Excluded patients (not receiving thromboembolic prophylaxis)
Number of subjects: 1510
Study: 354325

Group type: EXPERIMENTAL
Intervention: Fluspirilene every week
Number of subjects: 34

Group type: COMPARATOR
Intervention: Fluspirilene every two weeks
Number of subjects: 34
Study: 31726494

Group type: EXPERIMENTAL
Intervention: Retinal artery occlusion (RAO) patients
Number of subjects: 41
Study: 27386813

Group type: EXPERIMENTAL
Intervention: Combined training group (resistance + aerobic)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aerobic training group (AG)
Number of subjects: 20
Study: 25773496

Group type: EXPERIMENTAL
Intervention: GSK256073 5mg BID
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: GSK256073 10mg QD
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: GSK256073 25mg BID
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: GSK256073 50mg QD
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: GSK256073 (all doses)
Number of subjects: 94
Study: 23344510

Group type: EXPERIMENTAL
Intervention: Minilaparotomy cholecystectomy (MC)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 127
Study: 21198828

Group type: EXPERIMENTAL
Intervention: HALF index model for predicting significant fibrosis (SF)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Transient elastography (TE)
Number of subjects: 208
Study: 19169102

Group type: EXPERIMENTAL
Intervention: Elastic stable intramedullary nailing (ESIN)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonoperative treatment (simple shoulder sling)
Number of subjects: 60